Variant report

Variant	esv33053
Chromosome Location	chr19:41340629-41400635
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:442)
CpG islands
(count:733)
Chromatin interactive
region (count:5)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:442 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr19:41378197-41378436	K562	blood:	n/a	n/a
2	ARID3A	chr19:41370633-41370945	K562	blood:	n/a	n/a
3	ATF1	chr19:41378237-41378485	K562	blood:	n/a	n/a
4	ATF1	chr19:41370536-41370948	K562	blood:	n/a	n/a
5	ATF3	chr19:41378141-41378430	K562	blood:	n/a	n/a
6	ATF3	chr19:41370620-41370877	K562	blood:	n/a	n/a
7	CBX3	chr19:41381255-41381833	K562	blood:	n/a	n/a
8	CBX3	chr19:41347915-41348277	K562	blood:	n/a	n/a
9	CBX3	chr19:41349182-41350047	K562	blood:	n/a	n/a
10	CBX3	chr19:41379769-41380227	K562	blood:	n/a	n/a
11	CBX3	chr19:41370123-41371107	K562	blood:	n/a	n/a
12	CBX3	chr19:41379821-41380148	K562	blood:	n/a	n/a
13	CBX3	chr19:41347938-41348304	K562	blood:	n/a	n/a
14	CCNT2	chr19:41370582-41370786	K562	blood:	n/a	n/a
15	CEBPB	chr19:41370209-41371189	K562	blood:	n/a	chr19:41370433-41370441
16	CEBPB	chr19:41378202-41378474	K562	blood:	n/a	n/a
17	CEBPB	chr19:41343011-41343287	HepG2	liver:	n/a	chr19:41343121-41343132
18	CEBPB	chr19:41343058-41343265	A549	lung:	n/a	chr19:41343121-41343132
19	CEBPB	chr19:41373834-41374300	A549	lung:	n/a	n/a
20	CEBPB	chr19:41370305-41370801	K562	blood:	n/a	chr19:41370433-41370441
21	CEBPB	chr19:41374056-41374100	A549	lung:	n/a	n/a
22	CEBPB	chr19:41373920-41374208	K562	blood:	n/a	n/a
23	CEBPB	chr19:41378139-41378466	K562	blood:	n/a	n/a
24	CEBPB	chr19:41342957-41343295	K562	blood:	n/a	chr19:41343121-41343132
25	CEBPB	chr19:41343053-41343247	H1-hESC	embryonic stem cell:	n/a	chr19:41343121-41343132
26	CEBPB	chr19:41362024-41362201	K562	blood:	n/a	n/a
27	CEBPB	chr19:41343006-41343268	IMR90	lung:	n/a	chr19:41343121-41343132
28	CEBPB	chr19:41367289-41367476	A549	lung:	n/a	n/a
29	CEBPB	chr19:41368480-41368982	A549	lung:	n/a	n/a
30	CEBPB	chr19:41370543-41370910	K562	blood:	n/a	n/a
31	CEBPB	chr19:41368761-41369068	Hela-S3	cervix:	n/a	n/a
32	CEBPB	chr19:41368416-41368601	K562	blood:	n/a	n/a
33	CEBPB	chr19:41342862-41343338	A549	lung:	n/a	chr19:41343121-41343132
34	CEBPD	chr19:41392214-41392550	K562	blood:	n/a	n/a
35	CEBPD	chr19:41370295-41371143	K562	blood:	n/a	n/a
36	CEBPD	chr19:41370661-41370862	K562	blood:	n/a	n/a
37	CEBPZ	chr19:41395862-41395912	HepG2	liver:	n/a	n/a
38	CTCF	chr19:41368660-41368810	A549	lung:	n/a	n/a
39	CTCF	chr19:41368360-41368510	K562	blood:	n/a	n/a
40	CTCF	chr19:41364080-41364230	A549	lung:	n/a	n/a
41	CTCF	chr19:41354520-41354670	AG04449	skin:	n/a	n/a
42	CTCF	chr19:41354520-41354670	HBMEC	blood vessel:	n/a	n/a
43	CTCF	chr19:41354576-41354642	GM19239	blood:	n/a	n/a
44	CTCF	chr19:41354322-41355358	A549	lung:	n/a	chr19:41355271-41355289 chr19:41354699-41354709
45	CTCF	chr19:41354500-41354650	A549	lung:	n/a	n/a
46	CTCF	chr19:41354460-41354610	HRE	kidney:	n/a	n/a
47	CTCF	chr19:41349774-41349816	Lung_OC	lung:	n/a	n/a
48	CTCF	chr19:41368380-41368530	NHEK	skin:	n/a	n/a
49	CTCF	chr19:41386211-41386665	K562	blood:	n/a	n/a
50	CTCF	chr19:41386288-41386587	H1-hESC	embryonic stem cell:	n/a	n/a

(count:733 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:41385865-41385915	SKMC	muscle:	n/a
2	chr19:41385865-41385915	SKMC	muscle:	n/a
3	chr19:41354142-41354192	GM12892	blood:	n/a
4	chr19:41386441-41386491	H1-hESC	embryonic stem cell:	embryo
5	chr19:41355973-41356023	AG10803	skin:	n/a
6	chr19:41389684-41389734	BJ	skin:	n/a
7	chr19:41385865-41385915	T-47D	breast:	n/a
8	chr19:41354142-41354192	GM12891	blood:	n/a
9	chr19:41386507-41386557	SK-N-SH_RA	brain:	n/a
10	chr19:41355973-41356023	HCT-116	colon:	n/a
11	chr19:41351924-41351974	MCF-7	breast:	n/a
12	chr19:41385865-41385915	Hepatocyte	liver:	n/a
13	chr19:41383654-41383704	HRPEpiC	eye:	n/a
14	chr19:41388384-41388434	ovcar-3	ovarian:	n/a
15	chr19:41386441-41386491	HCPEpiC	choroid plexus:	n/a
16	chr19:41388384-41388434	PFSK-1	brain:	n/a
17	chr19:41351924-41351974	AG09309	skin:	n/a
18	chr19:41389684-41389734	PFSK-1	brain:	n/a
19	chr19:41355973-41356023	HMEC	breast:	n/a
20	chr19:41386507-41386557	CMK	blood:	n/a
21	chr19:41354553-41354603	BE2_C	brain:	n/a
22	chr19:41385865-41385915	PrEC	prostate:	n/a
23	chr19:41386441-41386491	HRE	kidney:	n/a
24	chr19:41388384-41388434	NHDF-neo	bronchial:	n/a
25	chr19:41351924-41351974	GM12892	blood:	n/a
26	chr19:41389684-41389734	Hela-S3	cervix:	n/a
27	chr19:41354553-41354603	SK-N-SH_RA	brain:	n/a
28	chr19:41389684-41389734	AG09309	skin:	n/a
29	chr19:41351924-41351974	ProgFib	skin:	n/a
30	chr19:41386507-41386557	GM19239	blood:	n/a
31	chr19:41385865-41385915	MCF-7	breast:	n/a
32	chr19:41389684-41389734	Hepatocyte	liver:	n/a
33	chr19:41383654-41383704	NT2-D1	testis:	n/a
34	chr19:41383654-41383704	IMR90	lung:	fetal
35	chr19:41386507-41386557	K562	blood:	n/a
36	chr19:41355973-41356023	HPAEpiC	pulmonary alveolar:	n/a
37	chr19:41385865-41385915	HCPEpiC	choroid plexus:	n/a
38	chr19:41383654-41383704	HAEpiC	amniotic membrane:	n/a
39	chr19:41386507-41386557	SKMC	muscle:	n/a
40	chr19:41386507-41386557	AoSMC	blood vessel:	n/a
41	chr19:41388232-41388282	HL-60	blood:	n/a
42	chr19:41354553-41354603	HRE	kidney:	n/a
43	chr19:41354682-41354732	HCPEpiC	choroid plexus:	n/a
44	chr19:41354553-41354603	HL-60	blood:	n/a
45	chr19:41388384-41388434	NB4	blood:	n/a
46	chr19:41355973-41356023	HEEpiC	esophagus:	n/a
47	chr19:41354553-41354603	IMR90	lung:	fetal
48	chr19:41386507-41386557	Caco-2	colon:	n/a
49	chr19:41386441-41386491	HCM	heart:	n/a
50	chr19:41388384-41388434	HPAEpiC	pulmonary alveolar:	n/a

(count:5 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:41369230..41371017-chr19:41372027..41374078,2	K562	blood:
2	chr19:41369230..41371017-chr19:41372027..41374078,2	K562	blood:
3	chr16:4474827..4477394-chr19:41351022..41353007,2	MCF-7	breast:
4	chr19:41195484..41197379-chr19:41368669..41371255,2	K562	blood:
5	chr19:41399908..41401580-chr19:41403170..41405832,2	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CYP2A6-1	chr19:41342991-41343115	ENSG00000269843.1

No data

Variant related genes	Relation type
ENSG00000269843	TF binding region
CYP2G1P	TF binding region
CYP2A6	TF binding region
CYP2A7	TF binding region
ENSG00000269843	CpG island
CYP2G1P	CpG island
CYP2A6	CpG island
CYP2A7	CpG island
ENSG00000262246	chromatin interactions
ENSG00000105245	chromatin interactions
ENSG00000103423	chromatin interactions

Extended variants
information (count: 3182 )
Associated
traits (count: 64 )

Variant overlapped rSNPs/rCNVs (count:3182 , 50 per page) page: 1 2 3 4 5 6 7 ... 64

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs376788431	chr19:41340629-41340630	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs182579069	chr19:41340634-41340635	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs536743512	chr19:41340635-41340636	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs369746826	chr19:41340645-41340646	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs374128775	chr19:41340696-41340697	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs563145311	chr19:41340705-41340706	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs187942643	chr19:41340711-41340712	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs192179809	chr19:41340714-41340715	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs557504626	chr19:41340717-41340718	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs577296785	chr19:41340748-41340749	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs541500790	chr19:41340749-41340750	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs567449195	chr19:41340814-41340815	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs534950663	chr19:41340836-41340837	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs34945948	chr19:41340842-41340843	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs184053846	chr19:41340857-41340858	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs544633394	chr19:41340882-41340883	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs77975282	chr19:41340908-41340909	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs188950929	chr19:41340926-41340927	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs28450491	chr19:41340937-41340938	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs575292025	chr19:41340943-41340944	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs142431808	chr19:41340944-41340945	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs12232853	chr19:41340957-41340958	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs11667314	chr19:41340983-41340984	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs371089284	chr19:41341008-41341009	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs561177979	chr19:41341065-41341066	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs192450413	chr19:41341074-41341075	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs535092574	chr19:41341081-41341082	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs184450974	chr19:41341114-41341115	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs568837748	chr19:41341131-41341132	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs138602029	chr19:41341151-41341152	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs557702881	chr19:41341175-41341176	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs572984736	chr19:41341188-41341189	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs34546511	chr19:41341192-41341193	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs534854805	chr19:41341202-41341203	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs188850192	chr19:41341221-41341222	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs74882516	chr19:41341222-41341223	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs12461964	chr19:41341229-41341230	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs542264480	chr19:41341294-41341295	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs563651802	chr19:41341311-41341312	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs34045178	chr19:41341326-41341327	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs368601045	chr19:41341337-41341338	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs374556229	chr19:41341351-41341352	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs191766986	chr19:41341383-41341384	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs367630946	chr19:41341392-41341393	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs117287096	chr19:41341413-41341414	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs564568971	chr19:41341514-41341515	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs184610142	chr19:41341525-41341526	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs189470339	chr19:41341545-41341546	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs181068436	chr19:41341580-41341581	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs7251418	chr19:41341589-41341590	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance

Variant related diseases (count:64)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Genital abnormality	22378287	CNVD
Hypospadia	22378287	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Astrocytoma	22246337	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:443 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:41330200-41349400	Weak transcription	Right Ventricle	heart
2	chr19:41333600-41349400	Weak transcription	Left Ventricle	heart
3	chr19:41336400-41340800	Enhancers	Fetal Intestine Large	intestine
4	chr19:41336600-41340800	Enhancers	Fetal Intestine Small	intestine
5	chr19:41338600-41344000	Weak transcription	A549	lung
6	chr19:41338800-41341000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
7	chr19:41339600-41349400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
8	chr19:41340000-41340800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
9	chr19:41340200-41341800	Enhancers	K562	blood
10	chr19:41341800-41349400	Weak transcription	K562	blood
11	chr19:41344000-41344400	Enhancers	A549	lung
12	chr19:41347600-41347800	Enhancers	Lung	lung
13	chr19:41347800-41349000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
14	chr19:41347800-41349800	Weak transcription	Lung	lung
15	chr19:41348800-41349000	Weak transcription	Primary T helper cells PMA-I stimulated	--
16	chr19:41348800-41349000	Weak transcription	Primary T killer memory cells from peripheral blood	blood
17	chr19:41349000-41349200	Enhancers	Primary neutrophils fromperipheralblood	blood
18	chr19:41349000-41349200	Enhancers	Primary T helper naive cells from peripheral blood	blood
19	chr19:41349000-41349200	Enhancers	Primary T helper cells PMA-I stimulated	--
20	chr19:41349000-41349200	Enhancers	Primary T helper cells fromperipheralblood	blood
21	chr19:41349000-41349200	Enhancers	Primary T killer naive cells fromperipheralblood	blood
22	chr19:41349000-41349200	Enhancers	Primary T killer memory cells from peripheral blood	blood
23	chr19:41349000-41349200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
24	chr19:41349000-41349200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
25	chr19:41349000-41349200	Enhancers	Duodenum Mucosa	Duodenum
26	chr19:41349000-41349400	Enhancers	Primary B cells from peripheral blood	blood
27	chr19:41349200-41349400	Enhancers	HUES48 Cell Line	embryonic stem cell
28	chr19:41349200-41349400	Enhancers	iPS-15b Cell Line	embryonic stem cell
29	chr19:41349200-41349400	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
30	chr19:41349200-41349400	Enhancers	Primary monocytes fromperipheralblood	blood
31	chr19:41349200-41349400	Enhancers	Primary T cells fromperipheralblood	blood
32	chr19:41349200-41349400	Flanking Active TSS	Primary T helper naive cells from peripheral blood	blood
33	chr19:41349200-41349400	Enhancers	Primary T helper naive cells fromperipheralblood	blood
34	chr19:41349200-41349400	Enhancers	Primary T regulatory cells fromperipheralblood	blood
35	chr19:41349200-41349400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
36	chr19:41349200-41349400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
37	chr19:41349200-41349400	Enhancers	Fetal Intestine Large	intestine
38	chr19:41349200-41349400	Enhancers	Fetal Thymus	thymus
39	chr19:41349200-41349400	Enhancers	GM12878-XiMat	blood
40	chr19:41349200-41349400	Enhancers	Monocytes-CD14+_RO01746	blood
41	chr19:41349200-41349600	Active TSS	Primary hematopoietic stem cells	blood
42	chr19:41349200-41349600	Flanking Active TSS	Primary T killer naive cells fromperipheralblood	blood
43	chr19:41349200-41349600	Flanking Active TSS	Primary T killer memory cells from peripheral blood	blood
44	chr19:41349200-41349600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
45	chr19:41349200-41349600	Flanking Active TSS	Duodenum Mucosa	Duodenum
46	chr19:41349200-41349600	Enhancers	Esophagus	oesophagus
47	chr19:41349200-41349600	Enhancers	Placenta	Placenta
48	chr19:41349200-41349600	Enhancers	Small Intestine	intestine
49	chr19:41349200-41349800	Active TSS	Breast Myoepithelial Primary Cells	Breast
50	chr19:41349200-41349800	Enhancers	Primary hematopoietic stem cells short term culture	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links